Dr Robert Stephen Porcella, MD | |
2262 Patricia Lane, Arnold, CA 95223 | |
(209) 795-1800 | |
Not Available |
Full Name | Dr Robert Stephen Porcella |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 2262 Patricia Lane, Arnold, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457641599 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | AFE18665 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robert Stephen Porcella, MD Po Box 6230, Arnold, CA 95223-6230 Ph: (209) 795-1800 | Dr Robert Stephen Porcella, MD 2262 Patricia Lane, Arnold, CA 95223 Ph: (209) 795-1800 |
News Archive
The Washington Post reports on the District of Columbia's Medicaid program and mental health coverage. "The federal government handed [the city] an opportunity to save $56 million over four years by expanding Medicaid this summer and they jumped at it. They switched 35,000 low-income residents from the city-funded D.C. Health Care Alliance insurance plan to a Medicaid plan and reaped the reward.
The Endocrine Society urges physicians to respond in a measured way to a recent study suggesting the diabetes drug Avandia (rosiglitazone) increases the risk of heart disease and heart attacks.
ABC News: "Summoning the message back that once mobilized his grass-roots campaign, the president spoke tonight in front of the same people - Organizing for America and DNC members - whose poll show some are feeling somewhat discouraged by the first year of the Obama administration. ... The president outlined in broad strokes what he'd like to see happen [on health reform]. 'What I'd like to do is have a meeting where I'm sitting with the Republicans, sitting with the Democrats.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Colesevelam HCI 625 mg tablets.
The justices could announce as early as Tuesday whether they will review provisions in the Affordable Care Act requiring employers of a certain size to offer insurance coverage for birth control and other reproductive health services without a co-pay. The owners of more than three dozen for-profit companies have argued that complying with that provision would violate their religious beliefs.
› Verified 7 days ago